Though there are molecular prognostic indicators of gliomas such as cell proliferation index, micro vessel density, loss of hereozygosity in 10q or 19q, MGMT promoter and IDH1 mutations6, the scale in this study is very simple and easy to use and can still offer great help for the moment. The gene discussed is MGMT; the disease is central nervous system cancer.